Further research on the regulation of autophagy by the HOTAIRM1-related signaling pathway is need and will help to elucidate the new mechanism of lenvatinib resistance, providing a theoretical basis for the prediction of lenvatinib therapy sensitivity in HCC and the development and application of new therapeutic targets for reversing lenvatinib resistance. The gene discussed is HOTAIRM1; the disease is hepatocellular carcinoma.